For ZIOPHARM Oncology, Inc. (ZIOP), It May Be A Good Moment

  • Summary:


    ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP)’s interesting series of developments are underway around the US stock market these days. Now trading with a market value of 899.07M, the company has a mix of catalysts and obstacles that spring from the nature of its operations. Everyone seems to have their own opinion of this stock. But what do the numbers really say? We think it’s a great time to take a fresh look.

    ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Fundamentals That Matter

    It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For ZIOP, the company currently has 88.42 million of cash on the books, which is ...



    Read Full News:

Log in to reply